Studies by Luo et al. have shown that inducing PD-L1 expression can lead to cell apoptosis and ferroptosis, enhancing the therapeutic effect of anti-PD-1 immunotherapy in non-small cell lung cancer (NSCLC), thus exerting an anti-cancer effect8. This evidence concerns the gene PDCD1 and cancer.